Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
TGF-1 promotes FLS migration and invasion by inducing epithelial-mesenchymal transition (EMT) via activating Smad-2/3 in RA (92)
Pietruski P, Paskal W, Paluch , Paskal AM, Nitek , Wodarski P, Walecki J, Noszczyk B
Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, et al
In contrast, relevant data for GLP-1 receptor agonists are limited to the recently published FLOW trial, which demonstrated substantial cardiorenal benefits with subcutaneous semaglutide in people with type 2 diabetes and CKD [22]
doi: 10.1021/acs.analchem.3c02442 38 GoY
Johansen NJ, Dejgaard TF, Lund A et al (2020) Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
US$ 23.22
US$ 23.33
US$ 21.69
US$ 29.82
